2010 - Review: Tiotropium does not increase risk for cardiovascular events in chronic obstructive pulmonary disease

Stanbrook, Matthew B.
July 2010
ACP Journal Club;7/20/2010, Vol. 153 Issue 1, p1
Academic Journal
The article presents the author's views on a research study which analyzed the risk of cardiovascular (CV) disease by use of tiotropium in patients with chronic obstructive pulmonary disease (COPD). The research had found that tiotropium doesn't increase CV risk in COPD patients. The author observes that the present study along with numerous other studies have established that tiotropium is more effective and convenient than other alternatives such as ipratropium in long-term COPD management.


Related Articles

  • ACP Journal Club. Review: In COPD, tiotropium improves lung function and reduces adverse events compared with ipratropium bromide. Maselli, Diego J.; Peters, Jay I. // Annals of Internal Medicine;1/19/2016, Vol. 164 Issue 2, pJC6 

    The article reports on a study regarding the comparison of efficacy of tiotropium and ipratropium bromide in patients with chronic obstructive pulmonary disease (COPD) that reveals that tiotropium increases FEV1 and improves lung disease in comparison to ipratropium bromide. Topics discussed...

  • Lung disease.  // New Zealand Doctor;4/10/2013, p30 

    The article reports on a study which shows the potential association of clarithromycin, a treatment for pneumonia and chronic obstructive pulmonary disease (COPD), and cardiovascular events.

  • Nrf Gun Against Bacterial Invaders.  // BioWorld Today;4/18/2011, Vol. 22 Issue 74, Special section p1 

    The article probes into a study by researchers from the Johns Hopkins University School of Medicine, which showed that targeting the protein Nrf2 could boost the ability of white blood cells to remove debris from the lungs and help treat chronic obstructive pulmonary disease (COPD).

  • Roflumilast of value in very severe COPD.  // PharmacoEconomics & Outcomes News;8/25/2007, Issue 535, p10 

    The article discusses a research on the cost effectiveness of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease (COPD). It references a study by Rutten-van Möken et al, published in "PharmacoEconomics." Researchers evaluated the cost effectiveness of...

  • COMMENTARY. Niewoehner, Dennis E. // Evidence Based Medicine;May2003, p74 

    The author discusses aspects of drug effectiveness wherein he recommends that an anticholinergic agent can be combined with beta blocker agonist in the treatment pf patients with chronic obstructive pulmonary disease (COPD).

  • Therapeutic strategies that work. Pennachio, Dorothy; Celli, Bartolome R.; Cosentino, Anthony; Fiel, Stanley; Petty, Thomas L. // Patient Care;3/15/1997, Vol. 31 Issue 5, p100 

    Discusses the use of therapeutic strategies for the treatment of chronic obstructive pulmonary disease (COPD). How smoking cessation and oxygen therapy can improve survival; Description of the goals of the treatment; Details on therapeutic treatments; Effectiveness of the strategies. INSETS:...

  • Evidence of efficacy during 10 years of use of tiotropium in COPD. Kostikas, Konstantinos; Loukides, Stelios // Hot Topics in Respiratory Medicine;2013, Issue 24, p7 

    Tiotropium bromide is a synthetic long-acting antimuscarinic agent that has been available for the management of stable COPD in several European countries since 2002 and in the US since January 2004. This agent is now an established option in our armamentarium of inhaled medication, being an...

  • Short course of antibiotic treatment in acute exacerbations of COPD.  // Thorax;May2008, Vol. 63 Issue 5, p390 

    The author reflects on the use of short course antibiotics in the treatment of acute exacerbations of chronic obstructive pulmonary disease (COPD). He suggests that antibiotics are essential when a patient with severe COPD presents with purulent sputum and systemic symptoms of infection. He...

  • Adjunctive Acupuncture Reduces COPD-Related Dyspnea. MOON, KENNETH T. // American Family Physician;12/15/2012, Vol. 86 Issue 12, p1150 

    The article discusses a study on the effectiveness of acupuncture in the treatment of dyspnea in patients with chronic obstructive pulmonary disease (COPD). It references a study by M. Suzuki et al published in the June 12, 2012 issue of "Archives of Internal Medicine." The study found that...

  • Albuterol dosing in treatment of acute episodes of COPD. Sadovsky, Richard // American Family Physician;11/1/1997, Vol. 56 Issue 7, p1874 

    Presents a summary of the article `Effect of Different Albuterol Dosing Regimens in the Treatment of Acute Exacebation of Chronic Obstructive Pulmonary Disease,' by C.L. Emerman and R.K. Cydulka from the journal `Annals of Emergency Medicine' dated 1997. Effects of high doses of albuterol;...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics